Elevance Health Q4 Ad. EPS Miss Market, Revenues Beat; Sees Growth In FY25, Lifts Dividend; Stock Up

(RTTNews) - Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 forecast, expecting year-over-year growth. Meanwhile, annual earnings are projected to be below the Street view.

Further, Elevance Health said its quarterly dividend has been increased by 5 percent to $1.71 per share, payable on March 25, to shareholders of record at the close of business on March 10.

In pre-market activity on the NYSE, Elevance Health shares were trading 6.2 percent higher at $415.00.

For fiscal 2025, the company projects earnings per share to be in the range of $30.40 to $31.10, and adjusted earnings per share in the range of $34.15 to $34.85. In fiscal 2024, the company reported earnings on a reported basis of $25.68 per share and adjusted earnings of $33.04 per share.

The Wall Street analysts on average expect the company to report earnings of $34.86 per share. Analysts' estimates typically exclude special items.

Total operating revenue for the year is expected to record high single to low double digit growth from prior year's $175.2 billion. The Street expect revenues of $188.18 billion for the year, a year-over-year growth of 7.53%.

For the fourth quarter, Elevance Health's profit decreased to $418 million or $1.81 per share from last year's $856 million or $3.63 per share.

Adjusted earnings were $888 million or $3.84 per share for the period, compared to $1.33 billion or $5.62 per share a year ago. The Street expected earnings of $3.86 per share for the quarter.

The company's revenue for the period rose 6.0 percent to $44.989 billion from $42.454 billion last year. The analysts expected revenues of $44.72 billion.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.